Elevated plasma malondialdehyde concentrations (OR 1.131), increased iNOS activity (OR 1.002), and decreased eNOS activity (OR 0.990) were identified as independent predictors of atrial high-rate episodes.
Cross-Sectional (n=180)
No
Are oxidative stress markers associated with Atrial High Rate Episodes (AHRE) in patients with cardiac implantable electronic devices?
180 patients with cardiac implantable electronic devices (CIEDs)
Presence of Atrial High Rate Episodes (AHRE) (n=78)
Absence of Atrial High Rate Episodes (AHRE) (n=102)
Association of AHRE with oxidative stress markers (NT-proBNP, MDA, nitric oxide, iNOS, eNOS)surrogate
Oxidative stress markers, specifically elevated MDA, increased iNOS activity, and decreased eNOS activity, are independent predictors of Atrial High Rate Episodes in patients with cardiac devices.
Effect estimate: OR 1.131 (95% CI 1.009-1.268)
Absolute Event Rate: 20.9% vs 19.1%
p-value: p=0.035
OBJECTIVE: Atrial High Rate Episodes (AHRE) are subclinical atrial tachyarrhythmias detectable by cardiac implantable electronic devices (CIEDs). AHREs have been associated with an increased risk of developing atrial fibrillation (AF), thromboembolism, cardiovascular and cerebrovascular events, and mortality. Although recent studies have assessed the value of oxidative stress markers in patients with AF, the relationships between AHRE and oxidative stress markers, including nitric oxide, has not yet been elucidated. This study aims to investigate the relationship between these markers and AHRE. METHOD: This prospective, cross-sectional study comprised 180 patients with CIEDs. The study population was divided into two groups based on the presence (n = 78) and absense (n = 102) of AHRE to analyze its association with biomarkers. RESULTS: The AHRE (+) group was significantly older, had a higher prevalence of hypertension, higher NT-proBNP (508.8 ± 249 pg/mL vs. 415.3 ± 292.1; P = 0.037), MDA levels (20.9 ± 4.1 μmol/L vs. 19.1 ± 3.1 μmol/L; P = 0.006), and iNOS activity (1,935.9 ± 326.1 pg/mL vs. 1,677.4 ± 363.2 pg/mL; P < 0.001). Logistic regression analysis identified age, hypertension, MDA (odds ratio OR: 1.131, 95%CI: 1.009 - 1.268, P = 0.035), inducible nitric oxide synthase (iNOS) activity (OR = 1.002, 95% CI = 1.001 - 1.003, P < 0.001), and endothelial nitric oxide synthase (eNOS) activity (OR = 0.990, 95% CI = 0.986 - 0.984, P < 0.001) as independent predictors of AHRE. CONCLUSION: The study findings indicated that plasma levels of NT-proBNP, MDA, nitric oxide, and the expression of iNOS and eNOS were significantly associated with AHRE. Moreover, elevated plasma MDA concentrations, increased iNOS activity, and decreased eNOS activity were identified as independent predictors of AHRE.
Building similarity graph...
Analyzing shared references across papers
Loading...
İnanç Artaç
Interventional Cardiology
Turk Kardiyoloji Dernegi Arsivi-Archives of the Turkish Society of Cardiology
Kafkas University
Building similarity graph...
Analyzing shared references across papers
Loading...
İnanç Artaç (Mon,) conducted a cross-sectional in Cardiac implantable electronic devices (CIEDs) (n=180). Presence of Atrial High Rate Episodes (AHRE) vs. Absence of AHRE was evaluated on Malondialdehyde (MDA) level as an independent predictor of AHRE (OR 1.131, 95% CI 1.009-1.268, p=0.035). Elevated plasma malondialdehyde concentrations (OR 1.131), increased iNOS activity (OR 1.002), and decreased eNOS activity (OR 0.990) were identified as independent predictors of atrial high-rate episodes.
synapsesocial.com/papers/6a0ea99753f874f2b2229d2c — DOI: https://doi.org/10.5543/tkda.2023.07433